| Quarter | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|
| 49 | 33 | 52 | 36 | 51 | 88 | 106 | |
Growth YoY Revenue Growth YoY% | 4.0 | 162.9 | 102.3 | ||||
| 32 | 27 | 38 | 23 | 36 | 72 | 80 | |
| 17 | 6 | 14 | 12 | 15 | 16 | 25 | |
OPM OPM% | 35.1 | 18.8 | 26.3 | 34.5 | 30.1 | 17.8 | 23.9 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Interest Expense Interest ExpenseCr | 1 | 1 | 1 | 2 | 1 | 1 | 1 |
Depreciation DepreciationCr | 1 | 0 | 0 | 0 | 0 | 1 | 1 |
PBT PBTCr | 15 | 5 | 12 | 11 | 14 | 14 | 23 |
| -1 | 1 | 3 | 5 | 3 | 5 | 6 | |
| 17 | 4 | 9 | 5 | 11 | 8 | 17 | |
Growth YoY PAT Growth YoY% | -33.5 | 133.2 | 84.3 | ||||
NPM NPM% | 34.0 | 10.7 | 17.9 | 14.5 | 21.8 | 9.5 | 16.3 |
| 5.2 | 0.9 | 0.0 | 0.1 | 0.2 | 0.2 | 0.3 |
| Quarter | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|
| 49 | 33 | 52 | 36 | 51 | 88 | 106 | |
Growth YoY Revenue Growth YoY% | 4.0 | 162.9 | 102.3 | ||||
| 32 | 27 | 38 | 23 | 36 | 72 | 80 | |
| 17 | 6 | 14 | 12 | 15 | 16 | 25 | |
OPM OPM% | 35.1 | 18.8 | 26.3 | 34.5 | 30.1 | 17.8 | 23.9 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Interest Expense Interest ExpenseCr | 1 | 1 | 1 | 2 | 1 | 1 | 1 |
Depreciation DepreciationCr | 1 | 0 | 0 | 0 | 0 | 1 | 1 |
PBT PBTCr | 15 | 5 | 12 | 11 | 14 | 14 | 23 |
| -1 | 1 | 3 | 5 | 3 | 5 | 6 | |
| 17 | 4 | 9 | 5 | 11 | 8 | 17 | |
Growth YoY PAT Growth YoY% | -33.5 | 133.2 | 84.3 | ||||
NPM NPM% | 34.0 | 10.7 | 17.9 | 14.5 | 21.8 | 9.5 | 16.3 |
| 5.2 | 0.9 | 0.0 | 0.1 | 0.2 | 0.2 | 0.3 |
| Financial Year | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|
Revenue RevenueCr | 120 | 172 | 280 |
Growth Revenue Growth% | 43.0 | ||
| 88 | 124 | 211 | |
| 32 | 48 | 68 | |
OPM OPM% | 26.8 | 27.6 | 24.5 |
| 0 | 0 | 0 | |
Interest Expense Interest ExpenseCr | 4 | 4 | 4 |
Depreciation DepreciationCr | 2 | 2 | 3 |
PBT PBTCr | 27 | 43 | 62 |
| 6 | 13 | 21 | |
PAT PATCr | 21 | 29 | 42 |
Growth PAT Growth% | 41.8 | ||
NPM NPM% | 17.1 | 16.9 | 14.9 |
| 6.4 | 0.6 | 0.8 |
| Financial Year | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|
Revenue RevenueCr | 120 | 172 | 280 |
Growth Revenue Growth% | 43.0 | ||
| 88 | 124 | 211 | |
| 32 | 48 | 68 | |
OPM OPM% | 26.8 | 27.6 | 24.5 |
| 0 | 0 | 0 | |
Interest Expense Interest ExpenseCr | 4 | 4 | 4 |
Depreciation DepreciationCr | 2 | 2 | 3 |
PBT PBTCr | 27 | 43 | 62 |
| 6 | 13 | 21 | |
PAT PATCr | 21 | 29 | 42 |
Growth PAT Growth% | 41.8 | ||
NPM NPM% | 17.1 | 16.9 | 14.9 |
| 6.4 | 0.6 | 0.8 |
| Financial Year | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|
Equity Capital Equity CapitalCr | 40 | 53 | 106 |
Reserves ReservesCr | 41 | 177 | 151 |
| 60 | 108 | 145 | |
| 41 | 12 | 12 | |
| 181 | 374 | 453 | |
| 158 | 308 | 369 | |
| 23 | 66 | 84 | |
| 181 | 374 | 453 |
| Financial Year | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|
Equity Capital Equity CapitalCr | 40 | 53 | 106 |
Reserves ReservesCr | 41 | 177 | 151 |
| 60 | 108 | 145 | |
| 41 | 12 | 12 | |
| 181 | 374 | 453 | |
| 158 | 308 | 369 | |
| 23 | 66 | 84 | |
| 181 | 374 | 453 |
| Financial Year | Mar 2025 | Mar 2026 |
|---|---|---|
| -22 | -59 | |
| 3 | -36 | |
| 19 | 118 | |
Net Cash Flow Net Cash FlowCr | 0 | 23 |
Free Cash Flow Free Cash FlowCr | -19 | -95 |
CFO To PAT CFO To PAT% | -106.7 | -202.5 |
CFO To EBITDA CFO To EBITDA% | -68.0 | -124.0 |
| Financial Year | Mar 2025 | Mar 2026 |
|---|---|---|
| -22 | -59 | |
| 3 | -36 | |
| 19 | 118 | |
Net Cash Flow Net Cash FlowCr | 0 | 23 |
Free Cash Flow Free Cash FlowCr | -19 | -95 |
CFO To PAT CFO To PAT% | -106.7 | -202.5 |
CFO To EBITDA CFO To EBITDA% | -68.0 | -124.0 |
| Financial Year | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|
Market Cap Market CapitalizationCr | 592 | 1,338 | |
Price To Earnings Price To Earnings | 20.8 | 30.7 | |
Price To Sales Price To Sales | 3.4 | 4.8 | |
Price To Book Price To Book | 2.6 | 5.2 | |
EV To EBITDA EV To EBITDA | 13.3 | 20.5 | |
GPM GPM% | 35.0 | 34.1 | 34.1 |
OPM OPM% | 26.8 | 27.6 | 24.5 |
NPM NPM% | 17.1 | 16.9 | 14.9 |
ROCE ROCE% | 20.8 | 16.9 | 20.0 |
ROE ROE% | 25.5 | 12.6 | 16.2 |
ROA ROA% | 11.3 | 7.8 | 9.2 |
| Financial Year | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|
Market Cap Market CapitalizationCr | 592 | 1,338 | |
Price To Earnings Price To Earnings | 20.8 | 30.7 | |
Price To Sales Price To Sales | 3.4 | 4.8 | |
Price To Book Price To Book | 2.6 | 5.2 | |
EV To EBITDA EV To EBITDA | 13.3 | 20.5 | |
GPM GPM% | 35.0 | 34.1 | 34.1 |
OPM OPM% | 26.8 | 27.6 | 24.5 |
NPM NPM% | 17.1 | 16.9 | 14.9 |
ROCE ROCE% | 20.8 | 16.9 | 20.0 |
ROE ROE% | 25.5 | 12.6 | 16.2 |
ROA ROA% | 11.3 | 7.8 | 9.2 |
| Market CapitalizationMkt CapCr | 4,432 | 4,422 | 3,050 | 1,338 | 1,313 | 795 | 627 |
| Close PriceClose₹ | 473.25 | 484.50 | 628.25 | 25.17 | 446.15 | 79.28 | 179.37 |
| IndustryIndustry | Pharma API | Pharma API | Pharma API | Pharma API | Pharma API | Pharma API | Pharma API |
| Price To EarningsPE | 37.38 | 19.34 | 82.02 | 30.70 | 25.02 | 16.62 | 11.13 |
| Price To SalesPS | 4.56 | 1.55 | 1.99 | 4.78 | 2.56 | 1.02 | 0.93 |
| RevenueRevenueCr | 971 | 2,851 | 1,535 | 280 | 513 | 778 | 676 |
| Revenue Growth TTMRev Gr TTM% | 13.0% | 15.1% | 27.3% | -8.8% | 6.6% | 7.5% | |
| PAT Growth TTMPAT Gr TTM% | 28.3% | 14.9% | 476.3% | -55.3% | 23.4% | 4.8% |
| Market CapitalizationMkt CapCr | 4,432 | 4,422 | 3,050 | 1,338 | 1,313 | 795 | 627 |
| Close PriceClose₹ | 473.25 | 484.50 | 628.25 | 25.17 | 446.15 | 79.28 | 179.37 |
| IndustryIndustry | Pharma API | Pharma API | Pharma API | Pharma API | Pharma API | Pharma API | Pharma API |
| Price To EarningsPE | 37.38 | 19.34 | 82.02 | 30.70 | 25.02 | 16.62 | 11.13 |
| Price To SalesPS | 4.56 | 1.55 | 1.99 | 4.78 | 2.56 | 1.02 | 0.93 |
| RevenueRevenueCr | 971 | 2,851 | 1,535 | 280 | 513 | 778 | 676 |
| Revenue Growth TTMRev Gr TTM% | 13.0% | 15.1% | 27.3% | -8.8% | 6.6% | 7.5% | |
| PAT Growth TTMPAT Gr TTM% | 28.3% | 14.9% | 476.3% | -55.3% | 23.4% | 4.8% |